Skip to main content

Find Clinical Trials

Home
Conditions
Graves Ophthalmopathy

Clinical trial condition

Graves Ophthalmopathy

Explore clinical trials studying Graves Ophthalmopathy. Study availability and eligibility vary by location and protocol.

138 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

Graves Ophthalmopathy trial results

Recruiting

The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

NCT07152340

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations: Shanghai Changzheng Hospital Changhua, Shanghai Municipality, China

Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

NCT07152366

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO

NCT07152392

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

NCT07124572

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Juan Ye Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy

NCT06590220

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy

NCT06927375

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT06112340

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +20 more
Locations: Bascom Palmer Eye Institute Miami, Florida, United States

West Virginia University Eye Institute Morgantown, West Virginia, United States

View Trial Details

Recruiting

Hydroxychloroquine in Mild Graves' Orbitopathy

NCT05126147

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +11 more
Locations: National Taiwan University Hospital, Hsin-Chu branch Hsinchu, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Recruiting

Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

NCT06392906

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Noi, Thailand

View Trial Details

Recruiting

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

NCT03131726

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations: Dpt. of Endocrinology, SUS Malmö Malmö, Sweden

View Trial Details